Cargando…
Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma
BACKGROUND: Human papillomavirus (HPV) testing in oropharyngeal squamous cell carcinoma (OPSCC) is now advocated. Demonstration of transcriptionally active high-risk HPV (HR-HPV) in fresh tumour tissue is considered to be the analytical ‘gold standard'. Clinical testing has focused on formalin-...
Autores principales: | Schache, A G, Liloglou, T, Risk, J M, Jones, T M, Ma, X-J, Wang, H, Bui, S, Luo, Y, Sloan, P, Shaw, R J, Robinson, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619267/ https://www.ncbi.nlm.nih.gov/pubmed/23412100 http://dx.doi.org/10.1038/bjc.2013.63 |
Ejemplares similares
-
The epigenetic landscape of oral squamous cell carcinoma
por: Jithesh, P V, et al.
Publicado: (2013) -
Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma
por: Schache, A G, et al.
Publicado: (2010) -
SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma
por: Dhanda, J, et al.
Publicado: (2014) -
Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study
por: Lefevre, Marine, et al.
Publicado: (2017) -
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
por: Ward, M J, et al.
Publicado: (2014)